Astena Holdings

8095.TWholesale Trade

Financials · Consolidated

Fiscal year ended	2025-11	2024-11	2023-11	2022-11	2021-11	2020-11
Revenue	¥62.7bn	¥58.0bn^r	¥52.0bn^r	¥49.6bn^r	¥72.3bn^r	¥65.3bn
Operating income	¥3.0bn	¥2.8bn^r	¥1.1bn	¥820m	¥2.2bn	—
Ordinary income	¥2.9bn	¥2.8bn^r	¥1.4bn^r	¥887m^r	¥2.4bn^r	¥2.0bn
Net income (owners)	¥2.2bn	−¥2.5bn^r	¥1.2bn^r	¥579m^r	¥1.7bn^r	¥2.0bn
Total assets	¥75.4bn	¥64.6bn^r	¥67.3bn^r	¥63.6bn^r	¥63.6bn^r	¥54.3bn
Net assets / equity	¥27.4bn	¥25.3bn^r	¥28.6bn^r	¥27.1bn^r	¥27.0bn^r	¥21.7bn
Operating cash flow	¥3.4bn	¥4.8bn^r	¥1.6bn^r	−¥742m^r	¥1.3bn^r	¥4.1bn
EPS (basic)	¥54.23	¥-63.18	¥29.47	¥14.56	¥46.86	¥60.33

From EDINET filings. Select any figure to open the report it came from. ^r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 4

All Annual 5 Half-year 2 Quarterly 7All years 2026 2025 2024 2023 2022

Period	Form	Filed	Figures
2022-12-01 → 2023-11-30	Annual	2024-02-28	203 figures · EDINET
2022-12-01 → 2023-08-31	Quarterly Q3	2023-10-13	49 figures · EDINET
2022-12-01 → 2023-05-31	Quarterly Q2	2023-07-13	73 figures · EDINET
2022-12-01 → 2023-02-28	Quarterly Q1	2023-04-14	47 figures · EDINET

24 more reports are still being processed.

Segments · FY ended 2025-11

Segment	External sales	Profit
Fine Chemicals	¥22.3bn	¥909m
Health And Beauty Care Food	¥18.2bn	¥700m
Industrial Chemicals	¥9.7bn	¥733m
Medical	¥12.4bn	¥1.1bn
Other segments	¥57m	−¥363m
Adjustments & eliminations	—	−¥80m
Total	¥62.7bn	¥3.5bn
Total	¥62.7bn	¥3.1bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.